• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join

Photo

RepliCel’s Phase 1 Clinical Trial For Hair Loss Succeeds In Meeting Primary Endpoints

Started by alc , Mar 15 2017 01:57 AM
replicel male and female androgenetic alopecia

  • Please log in to reply
No replies to this topic

#1 alc

  • Validating/Suspended
  • 208 posts
  • 102 ₮
  • Location:Columbus, OH
  • NO

Posted 15 March 2017 - 01:57 AM


"RepliCel’s Phase 1 Clinical Trial For Hair Loss Succeeds In Meeting Primary Endpoints"

Five-year safety data firmly establishes product safety and confirms ongoing clinical and product development strategy

 

http://replicel.com/20170314-2/


Back to Retailer/Product Discussion

Also tagged with one or more of these keywords: replicel, male and female androgenetic alopecia

3 user(s) are reading this topic

0 members, 3 guests, 0 anonymous users

  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Retailer/Product Discussion
  5. site rules